SOSV

Kotal is a developer of cloud-native deployment tools focused on managing the lifecycle of blockchain infrastructure. Founded in 2020 and based in Middletown, Delaware, the company offers a platform that facilitates the deployment of self-managing and self-healing blockchain systems for clients. Its platform includes a range of features such as open-source tools, protocol agnosticism, key management, and multi-client support. These features enable clients to effectively oversee all aspects of blockchain infrastructure, from deployment and integration to security, logging, and monitoring.

Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.

AYLIEN, headquartered in Wilmington, Delaware, specializes in artificial intelligence and machine learning solutions for natural language processing. The company offers a news intelligence platform that enables users to understand and analyze large volumes of human-generated content, such as text and images, at scale. Their tools include Text Analysis and News APIs, designed to help machines comprehend human languages better, benefiting developers, data scientists, marketers, and academics. Additionally, AYLIEN provides a micro application development platform, Talk.ee, which collects and categorizes global information, and a news ticker tool to keep readers updated on topics of interest.

Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.

Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.

AYLIEN, headquartered in Wilmington, Delaware, specializes in artificial intelligence and machine learning solutions for natural language processing. The company offers a news intelligence platform that enables users to understand and analyze large volumes of human-generated content, such as text and images, at scale. Their tools include Text Analysis and News APIs, designed to help machines comprehend human languages better, benefiting developers, data scientists, marketers, and academics. Additionally, AYLIEN provides a micro application development platform, Talk.ee, which collects and categorizes global information, and a news ticker tool to keep readers updated on topics of interest.

Bioptamers, Inc. is a biotechnology company focused on developing cellular and gene therapies for cancer treatment. Founded in 2018 and headquartered in New Castle, Delaware, with an additional office in São Paulo, Brazil, the company aims to create personalized therapeutic delivery technologies using monoclonal antibodies and antibody-drug conjugates. Bioptamers is working on optimizing aptamer selection to tailor cancer therapies to individual patient needs. This process involves creating DNA aptamers that specifically bind to cancer cells, facilitating personalized precision therapies. By transforming these molecules into clinically valuable products, Bioptamers seeks to license them to pharmaceutical companies and improve clinical outcomes for cancer patients in collaboration with private companies and hospitals.

Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.

AYLIEN, headquartered in Wilmington, Delaware, specializes in artificial intelligence and machine learning solutions for natural language processing. The company offers a news intelligence platform that enables users to understand and analyze large volumes of human-generated content, such as text and images, at scale. Their tools include Text Analysis and News APIs, designed to help machines comprehend human languages better, benefiting developers, data scientists, marketers, and academics. Additionally, AYLIEN provides a micro application development platform, Talk.ee, which collects and categorizes global information, and a news ticker tool to keep readers updated on topics of interest.

AYLIEN, headquartered in Wilmington, Delaware, specializes in artificial intelligence and machine learning solutions for natural language processing. The company offers a news intelligence platform that enables users to understand and analyze large volumes of human-generated content, such as text and images, at scale. Their tools include Text Analysis and News APIs, designed to help machines comprehend human languages better, benefiting developers, data scientists, marketers, and academics. Additionally, AYLIEN provides a micro application development platform, Talk.ee, which collects and categorizes global information, and a news ticker tool to keep readers updated on topics of interest.

AYLIEN, headquartered in Wilmington, Delaware, specializes in artificial intelligence and machine learning solutions for natural language processing. The company offers a news intelligence platform that enables users to understand and analyze large volumes of human-generated content, such as text and images, at scale. Their tools include Text Analysis and News APIs, designed to help machines comprehend human languages better, benefiting developers, data scientists, marketers, and academics. Additionally, AYLIEN provides a micro application development platform, Talk.ee, which collects and categorizes global information, and a news ticker tool to keep readers updated on topics of interest.

AYLIEN, headquartered in Wilmington, Delaware, specializes in artificial intelligence and machine learning solutions for natural language processing. The company offers a news intelligence platform that enables users to understand and analyze large volumes of human-generated content, such as text and images, at scale. Their tools include Text Analysis and News APIs, designed to help machines comprehend human languages better, benefiting developers, data scientists, marketers, and academics. Additionally, AYLIEN provides a micro application development platform, Talk.ee, which collects and categorizes global information, and a news ticker tool to keep readers updated on topics of interest.